Sinopharm
1099.HK
#2265
Rank
โ‚ฌ6.90 B
Marketcap
2,21ย โ‚ฌ
Share price
-1.47%
Change (1 day)
-10.37%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2024: โ‚ฌ1.96 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚ฌ80.09 Billion. In 2024 the company made an earning of โ‚ฌ1.96 Billion a decrease over its 2023 earnings that were of โ‚ฌ2.72 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2024

Annual earnings

Year Earnings Change
2024โ‚ฌ1.96 B-27.86%
2023โ‚ฌ2.72 B-0.73%
2022โ‚ฌ2.74 B-1.72%
2021โ‚ฌ2.79 B11.7%
2020โ‚ฌ2.50 B18.44%
2019โ‚ฌ2.11 B10.85%
2018โ‚ฌ1.90 B3.05%
2017โ‚ฌ1.85 B36.48%
2016โ‚ฌ1.35 B7.11%
2015โ‚ฌ1.26 B12.38%
2014โ‚ฌ1.12 B25.05%
2013โ‚ฌ0.90 B22.54%
2012โ‚ฌ0.73 B35.43%
2011โ‚ฌ0.54 B52.24%
2010โ‚ฌ0.35 B30.99%
2009โ‚ฌ0.27 B60.59%
2008โ‚ฌ0.16 B48.29%
2007โ‚ฌ0.11 B123.29%
2006โ‚ฌ51.2 M